Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset Seizures

• Status: Completed
• Trial end date: 2010-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to allow eligible subjects from the parent study, SP925 [NCT00655551] to continue lacosamide and to obtain additional long-term safety data

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: UCB BIOSCIENCES, Inc.
• Treatments: Lacosamide

Criteria

Inclusion Criteria:

• Eligible subjects who participated in SP925 [NCT00655551] for treatment of partial-onset seizures

Exclusion Criteria:

• Receiving any study drug or experimental device other than lacosamide

• Meets withdrawal criteria for parent study SP925 [NCT00655551]

• Experiencing ongoing serious adverse event